National Institute Of Neurological Disorders And Stroke (ninds)
Clinical trials sponsored by National Institute Of Neurological Disorders And Stroke (ninds), explained in plain language.
-
Experimental shot aims to quiet cancer pain in bones
Symptom relief Not yet recruitingThis early-stage trial tests whether an injected drug called resiniferatoxin (RTX) can safely reduce severe bone pain caused by cancer that hasn't responded to standard treatments. About 30 adults with advanced cancer will receive a single injection into the spine and be followed…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated May 26, 2026 03:01 UTC
-
Cancer drug could tame long COVID brain fog
Symptom relief Not yet recruitingThis early-stage trial tests whether a single dose of pembrolizumab, a drug used for cancer, can safely reduce long-term neurological symptoms like brain fog, headache, and dizziness after COVID-19. Fifteen adults who had COVID at least 6 months ago and still have these symptoms …
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Symptom relief
Last updated May 26, 2026 02:52 UTC